TOKYO-Monday 20 June 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) officially announced today that an organoarsenic drug “DARVIAS® Injection 135mg” (SP-02, hereinafter DARVIAS®) has been approved for relapsed or refractory Peripheral T-Cell Lymphoma (hereinafter “PTCL”) by the Ministry of Health, Labor and Welfare (MHLW). Solasia filed an NDA with the MHLW in Japan in June 2021. In October 2021, Nippon Kayaku Co., Ltd. (TSE: 4272, Headquarters: Tokyo, Japan, President: Atsuhiro Wakumoto) secured a license agreement with DARVIAS® for marketing rights in Japan.
DARVIAS®, an organoarsenic compound with anticancer activity, is a novel mitochondrial-targeted agent being developed for the treatment of various hematologic and solid tumors. The proposed mechanism of action of the drug involves the disruption of m
...
Read more »
|
Acronis’ expertise in data protection and the managed service provider market yields an innovative, fast-track approach for the prevention of catastrophic data leaks
Dubai, United Arab Emirates-Monday 20 June 2022 [ AETOS Wire ]
Acronis, the global leader in cyber protection, has debuted a new Advanced Data Loss Prevention (DLP) pack for Acronis Cyber Protect Cloud, a game-changing solution that shields managed service providers (MSPs) and businesses of all sizes from data leakage. Notably, the solution does not require months for deployment, and highly skilled teams to maintain it.
Drawing from decades-long experience enabling MSPs in data protection, this expansion resolves the main obstacles hindering the broader adoption of DLP solutions: grueling roll-out and cumbersome ongoing administrative execution.
For years, organizations have struggled to protect sensitive data from unauthorized access via external attacks or insider risks such a
...
Read more »
|
VIENNA-Monday 20 June 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- AOP Health announced the final results on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from its CONTINUATION-PV study in an oral presentation at the prestigious EHA (European Hematology Association) 2022 Annual Meeting by Professor Heinz Gisslinger, Medical University of Vienna, Austria 1.
Link to abstract
Ropeginterferon alfa-2b is a long-acting, mono-pegylated proline interferon (ATC L03AB15). It is administered once every 2 weeks initially, or up to monthly after stabilization of hematological parameters.
AOP Health has been conducting a pivotal clinical development program, including the studies PEGINVERA, PROUD-PV and CONTINUATION-PV. The latter is an open-label, multicenter, phase IIIb study assessing the long-term efficacy and safety of Ropeginterferon alfa-2b versus hydroxyurea (HU) or best available treatment (BAT) in patients with PV who previously participated
...
Read more »
|
NUREMBERG, Germany-Monday 20 June 2022 [ AETOS Wire ]
(BUSINESS WIRE) -- Quectel Wireless Solutions, a global IoT solutions provider, today announced the release of its LC76G module, a single-band compact GNSS module featuring fast and accurate location performance as well as ultra-low power consumption. The LC76G has already entered mass production with sufficient supply to meet the needs of the global positioning market.
Based on the Airoha AG3352 platform, the LC76G can concurrently receive and process signals from all constellations (GPS, GLONASS, BeiDou, Galileo and QZSS), which in combination with the support of SBAS greatly increases the number of visible satellites and enhances positioning accuracy. The LC76G module can receive signals from up to 47 satellites and achieve 1.5m (CEP50 open-sky) positioning accuracy representing a 40% improvement over previous generations of devices.
Available in a cost-optimized version as well as a low-power version,
...
Read more »
|
CHESTERBROOK, Pa-Thursday 16 June 2022 [ AETOS Wire ]
After the $4 billion transaction to become a standalone company, Boomi recently set the industry record for largest customer base with more than 20,000 global customers
World-class leaders with past experience from PayPal, Red Hat, VMware, NBC Boston, and Accenture, with excellent academic credentials including Stanford Business School, and an Emmy-award winner, all join SaaS category-leader, Boomi, to support the company’s rapid growth
Winning numerous awards for product excellence and culture, such as recently obtaining the Gold Globee® Award in the Platform as a Service category, and being named as one of Inc. Magazine’s Best Workplaces, Boomi plans to hire several hundred more employees globally by year’s end
(BUSINESS WIRE) -- Boomi™, the intelligent connectivity and automation leader, today announced the appo
...
Read more »
|
|